Cercar
01/03/2023
Essential protein P116 extracts cholesterol and other indispensable lipids for Mycoplasmas
Sprankel L., Vizarraga D., Martín J., Manger S., Meier-Credo J., Marcos M., Julve J., Rotllan N., Scheffer M.P., Escolà-Gil J.C., Langer J.D., Piñol J., Fita I., Frangakis A.S.. Essential protein P116 extracts cholesterol and other indispensable lipids for Mycoplasmas. NATURE STRUCTURAL & MOLECULAR BIOLOGY. 2023; 30(3)DOI:10.1038/s41594-023-00922-y. PMID:36782049. IF:12.500(Q1/1D).
01/03/2023
Caffeine and the Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus: Findings from Clinical and Experimental Studies
Alcubierre, N, Granado-Casas, M, Bogdanov, P, Hernandez, C, Ramos, H, Castelblanco, E, Real, J, Rubinat-Arnaldo, E, Traveset, A, Hernandez, M, Jurjo, C, Vioque, J, Navarrete-Munoz, EM, Simo, R, Mauricio, D. Caffeine and the Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus: Findings from Clinical and Experimental Studies. Nutrients. 2023; 15(5)DOI:10.3390/nu15051169. PMID:36904168. IF:4.800(Q1/2D).
01/03/2023
Fatty Acid Binding Proteins 3 and 4 Predict Both All-Cause and Cardiovascular Mortality in Subjects with Chronic Heart Failure and Type 2 Diabetes Mellitus
Rodriguez-Calvo, R, Granado-Casas, M, de Oca, APM, Julian, MT, Domingo, M, Codina, P, Santiago-Vacas, E, Cediel, G, Julve, J, Rossell, J, Masana, L, Mauricio, D, Lupon, J, Bayes-Genis, A, Alonso, N. Fatty Acid Binding Proteins 3 and 4 Predict Both All-Cause and Cardiovascular Mortality in Subjects with Chronic Heart Failure and Type 2 Diabetes Mellitus. Antioxidants. 2023; 12(3)DOI:10.3390/antiox12030645. PMID:36978893. IF:6.000(Q1/2D).
01/03/2023
Circulating Small Noncoding RNA Profiling as a Potential Biomarker of Atherosclerotic Plaque Composition in Type 1 Diabetes
Giannella, A, Castelblanco, E, Zambon, CF, Basso, D, Hernandez, M, Ortega, E, Alonso, N, Mauricio, D, Avogaro, A, Ceolotto, G, Vigili de Kreutzenberg, S. Circulating Small Noncoding RNA Profiling as a Potential Biomarker of Atherosclerotic Plaque Composition in Type 1 Diabetes. DIABETES CARE. 2023; 46(3)DOI:10.2337/dc22-1441. PMID:36577032. IF:14.800(Q1/1D).
01/03/2023
Circulating metabolomic and lipidomic changes in subjects with new-onset type 1 diabetes after optimization of glycemic control
Julve, J, Genua, I, Quifer-Rada, P, Yanes, O, Barranco-Altirriba, M, Hernandez, M, Junza, A, Capellades, J, Granado-Casas, M, Alonso, N, Castelblanco, E, Mauricio, D. Circulating metabolomic and lipidomic changes in subjects with new-onset type 1 diabetes after optimization of glycemic control. DIABETES RESEARCH AND CLINICAL PRACTICE. 2023; 197DOI:10.1016/j.diabres.2023.110578. PMID:36804334. IF:6.100(Q1/2D).
28/02/2023
Prediction of outcomes in subjects with type 2 diabetes and diabetic foot ulcers in Catalonian primary care centers: a multicenter observational study
Bundo, M, Vlacho, B, Llussa, J, Bobe, I, Aivar, M, Ciria, C, Martinez-Sanchez, A, Real, J, Mata-Cases, M, Cos, X, Doria, M, Viade, J, Franch-Nadal, J, Mauricio, D. Prediction of outcomes in subjects with type 2 diabetes and diabetic foot ulcers in Catalonian primary care centers: a multicenter observational study. Journal of Foot and Ankle Research. 2023; 16(1)DOI:10.1186/s13047-023-00602-6. PMID:36849888. IF:2.500(Q1/3D).